We are a leading global
healthcare company, founded in 1923 and headquartered in Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
We employ about 42,700 people in 80 countries and market our
products in around 170 countries.
The Novo Nordisk Way -
who we are, where we want to go and how we work
Each and every employee is responsible for acting in accordance with the Novo Nordisk Way - and to help each other understand what it means in practice.
The Triple Bottom Line -
our way of doing business
We have built our business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. That is why we manage our business in accordance with the Triple Bottom Line principle.
The story of Novo Nordisk goes back more than 90 years
It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.